Clinical Challenges: Current Treatment for Axial Spondyloarthritis
A widening array of medications has changed the course of disease
Stay updated with breaking news from Necrosis Factor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A widening array of medications has changed the course of disease
Houston, TX, June 8, 2023 - (ACN Newswire) - Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing multiple therapeutic programs intended to
Houston, TX, June 8, 2023 - (ACN Newswire) - Coya Therapeutics, Inc. (NASDAQ: COYA) ('Coya' or the 'Company'), a clinical-stage biotechnology company developing multiple therapeutic programs intended to enhance Treg function, including ...
Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease
Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer's Disease